Clik here to view.
Retina Implant drums up $28m
Retina Implant said this week that it raised $28.2 million (€26 million) in private equity funding for its Alpha IMS device, which is designed to treat blind patients with retinitis pigmentosa. The...
View ArticleClik here to view.
FDA approves Edwards Lifesciencies Sapien XT for pulmonary valve procedures
Edwards Lifesciences (NYSE:EW) said today that it won FDA approval for the use of its Sapien XT replacement heart valve in adult and pediatric patients with conditions affecting their pulmonary valves....
View ArticleClik here to view.
FDA warns ReWalk on lack of post-market surveillance for exoskeleton
The FDA today released a warning letter it sent to ReWalk Robotics (NSDQ:RWLK), formerly Argo Medical, over a failure to submit a post-market surveillance report on its ReWalk exoskeleton device...
View ArticleClik here to view.
Johnson & Johnson launches JLABS incubator in Houston
Johnson & Johnson (NYSE:JNJ) said today it launched JLABS life science incubator in Houston, designed to provide shared lab space, offices and laboratory suites and equipment for up to 50 startups....
View ArticleClik here to view.
Zimmer Biomet buys Ortho Transmission’s direct-to-skeleton prosthetic...
Zimmer Biomet (NYSE:ZBH) said yesterday that it acquired Ortho Transmission and its transcutaneous osseous integrated skeletal implant technology for an undisclosed amount. The buyout dovetails with...
View ArticleClik here to view.
InVivo adds Greenville, N.C. site to Inspire neuro-spinal scaffold study
InVivo Therapeutics (NSDQ:NVIV) said today it added a clinical site at the Vidant Medical Center in Greenville, N.C.to its Inspire study examining the probable benefit of its Neuro-Spinal Scaffold,...
View ArticleClik here to view.
Nevro promotes prez Elghandour to replace CEO DeMane | Personnel Moves
Nevro Corp. (NYSE:NVRO) this week promoted president Rami Elghandour to be its new CEO, as chief executive Michael DeMane moves to the executive chairman spot. DeMane, the former COO at Medtronic, will...
View ArticleClik here to view.
Cantel Medical closes $13.5m buy of NAMSA’s sterility assurance biz
Cantel Medical (NYSE:CMN) said today it closed its $13.5 million buy of North American Science Associates sterility assurance business, which Cantel said it plans to fold into its Crosstex division....
View ArticleClik here to view.
MassDevice.com +3 | The top 3 medtech stories for March 2, 2016
Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the...
View ArticleClik here to view.
AOSS roundup: JNJ inks deal for bundled payments for hip & knee replacements
Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes today announced an exclusive strategic alliance with Value Stream Partners, a company specializing in knee and hip replacement bundled payment...
View ArticleClik here to view.
Recent US FDA regulatory updates you should know about
By Stewart Eisenhart, Emergo Group The US FDA has been busy since late 2015, issuing several new and updated guidance documents related to Human Factors, eCopy submissions, oversight of lab developed...
View ArticleClik here to view.
Virtual Incision’s inside-the-body surgical robot logs 1st-in-human use
Virtual Incision this week announced the 1st-in-human use of its miniaturized robotically assisted surgical device, which was used in a colon resection procedures in Paraguay. The RASD is designed to...
View ArticleClik here to view.
FDA approves Medtronic’s Specify SureScan MRI-safe neurostim leads
Medtronic (NYSE:MDT) said today that the FDA approved its MRI-safe Specify SureScan spinal cord stimulation leads for treating chronic pain. The Fridley, Minn.-based medtech titan said the approval...
View ArticleClik here to view.
Sunshine Heart halts trial, ousts CEO Rosa
Sunshine Heart (NSDQ:SSH) said today that it replace CEO David Rosa with John Erb and halted a pair of clinical trials of its C-Pulse heart failure device. The C-Pulse system is designed to use...
View ArticleClik here to view.
Gore wins FDA nod for Excluder stent graft
W.L. Gore & Assoc. said today that it won FDA approval for its Excluder stent graft for treating abdominal aortic aneurisms. The Excluder device is designed to treat aneurysms in the iliac arteries...
View ArticleClik here to view.
Johnson & Johnson unit inks spine implant development deal with Rainbow Medical
Rainbow Medical said today that it inked a deal with a unit of Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes to co-develop a minimally invasive implant to treat degenerative disc disease....
View ArticleClik here to view.
FDA clears Zimmer Biomet’s elbow-shoulder combo
Zimmer Biomet (NYSE:ZBH) said today that the FDA cleared the combination of its Nexel total elbow system and the Comprehensive segmental revision system, which the company said was its 1st clearance...
View ArticleClik here to view.
Novocure wins reimbursement from Humana for Optune brain cancer device
NovoCure (NSDQ:NVCR) said today it won reimbursement from Humana for treatments with its Optune device for patients with recurrent glioblastoma. The Optune is a mobile device that delivers...
View ArticleClik here to view.
InVivo continues the roll, adds another site to Inspire study
InVivo Therapeutics (NSDQ:NVIV) is continuing its momentum, saying today it added another clinical site, this time at the University of Louisville Hospital in Ky., to the Inspire trial testing its...
View ArticleClik here to view.
Boston Scientific releases ureteral stent tracker app
Boston Scientific (NYSE:BSX) has launched a new app designed to help urologists track ureteral stents implanted in patients with kidney stones. The app was developed as a joint operation between the...
View Article
